Silver Lake Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.92M Hold
3,532,276
0.19% 7
2025
Q4
$9.57M Hold
3,532,276
0.19% 7
2025
Q3
$14.9M Hold
3,532,276
0.29% 8
2025
Q2
$17.6M Hold
3,532,276
0.35% 8
2025
Q1
$15.6M Hold
3,532,276
0.28% 9
2024
Q4
$16.4M Hold
3,532,276
0.19% 9
2024
Q3
$24.5M Hold
3,532,276
0.28% 11
2024
Q2
$27.6M Hold
3,532,276
0.34% 11
2024
Q1
$25.1M Hold
3,532,276
0.3% 11
2023
Q4
$23.7M Hold
3,532,276
0.27% 12
2023
Q3
$19.9M Hold
3,532,276
0.14% 12
2023
Q2
$19.5M Hold
3,532,276
0.13% 12
2023
Q1
$22.1M Hold
3,532,276
0.16% 13
2022
Q4
$16.5M Hold
3,532,276
0.13% 14
2022
Q3
$16.5M Hold
3,532,276
0.15% 15
2022
Q2
$20.9M Hold
3,532,276
0.16% 16
2022
Q1
$68.3M Hold
3,532,276
0.38% 16
2021
Q4
$115M Hold
3,532,276
0.54% 14
2021
Q3
$145M Hold
3,532,276
0.89% 12
2021
Q2
$127M Buy
3,532,276
+501,973
+17% +$18.5M 0.87% 11
2021
Q1
$118M Hold
3,030,303
1.18% 8
2020
Q4
$122M Hold
3,030,303
1.05% 8
2020
Q3
$168M Buy
+3,030,303
New +$160M 2.07% 6

Other funds holding GDRX

Silver Lake Group's GDRX Position: Q1 2026 in Review

Silver Lake Group held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 3,532,276 shares worth $6.92M. The position accounts for 0.19% of the portfolio, ranked #7.

Silver Lake Group first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $168M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Silver Lake Group held 3,532,276 shares of GoodRx Holdings worth $6.92M as of Q1 2026.
  • Silver Lake Group left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up 0.19% of Silver Lake Group's portfolio in Q1 2026, its #7 holding.
  • Silver Lake Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • Silver Lake Group's GoodRx Holdings position peaked at $168M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Silver Lake Group's 13F filing for Q1 2026, filed 15 May 2026.